Gerth, W. C., Betschel, S. D., & Zbrozek, A. S. (2014). Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada. BioMed Central.
Chicago Style aipamenaGerth, William C., Stephen D. Betschel, and Arthur S. Zbrozek. Implications to Payers of Switch From Hospital-based Intravenous Immunoglobulin to Home-based Subcutaneous Immunoglobulin Therapy in Patients With Primary and Secondary Immunodeficiencies in Canada. BioMed Central, 2014.
MLA aipamenaGerth, William C., Stephen D. Betschel, and Arthur S. Zbrozek. Implications to Payers of Switch From Hospital-based Intravenous Immunoglobulin to Home-based Subcutaneous Immunoglobulin Therapy in Patients With Primary and Secondary Immunodeficiencies in Canada. BioMed Central, 2014.